nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—HTR7—vas deferens—urinary bladder cancer	0.0712	0.288	CbGeAlD
Amoxapine—HTR2A—urine—urinary bladder cancer	0.011	0.0447	CbGeAlD
Amoxapine—CYP2D6—urine—urinary bladder cancer	0.0101	0.0408	CbGeAlD
Amoxapine—ORM1—prostate gland—urinary bladder cancer	0.0088	0.0356	CbGeAlD
Amoxapine—CHRM1—prostate gland—urinary bladder cancer	0.00747	0.0302	CbGeAlD
Amoxapine—ADRA1A—prostate gland—urinary bladder cancer	0.00614	0.0248	CbGeAlD
Amoxapine—HTR2B—smooth muscle tissue—urinary bladder cancer	0.00526	0.0213	CbGeAlD
Amoxapine—ORM1—female reproductive system—urinary bladder cancer	0.0048	0.0194	CbGeAlD
Amoxapine—HRH1—prostate gland—urinary bladder cancer	0.00475	0.0192	CbGeAlD
Amoxapine—HTR7—epithelium—urinary bladder cancer	0.00467	0.0189	CbGeAlD
Amoxapine—ADRA2A—prostate gland—urinary bladder cancer	0.00466	0.0189	CbGeAlD
Amoxapine—HTR1A—renal system—urinary bladder cancer	0.00454	0.0184	CbGeAlD
Amoxapine—ADRA1A—epithelium—urinary bladder cancer	0.00451	0.0183	CbGeAlD
Amoxapine—HTR7—smooth muscle tissue—urinary bladder cancer	0.0045	0.0182	CbGeAlD
Amoxapine—HTR1B—female reproductive system—urinary bladder cancer	0.0045	0.0182	CbGeAlD
Amoxapine—HTR7—renal system—urinary bladder cancer	0.00434	0.0176	CbGeAlD
Amoxapine—HTR2C—female reproductive system—urinary bladder cancer	0.00432	0.0175	CbGeAlD
Amoxapine—ADRA1A—renal system—urinary bladder cancer	0.00418	0.0169	CbGeAlD
Amoxapine—SLC6A4—female reproductive system—urinary bladder cancer	0.00409	0.0166	CbGeAlD
Amoxapine—CHRM1—female reproductive system—urinary bladder cancer	0.00408	0.0165	CbGeAlD
Amoxapine—HTR2B—female reproductive system—urinary bladder cancer	0.00405	0.0164	CbGeAlD
Amoxapine—ADRA2A—seminal vesicle—urinary bladder cancer	0.00395	0.016	CbGeAlD
Amoxapine—HTR2B—vagina—urinary bladder cancer	0.00367	0.0148	CbGeAlD
Amoxapine—SLC6A2—female reproductive system—urinary bladder cancer	0.0036	0.0146	CbGeAlD
Amoxapine—HRH1—epithelium—urinary bladder cancer	0.00349	0.0141	CbGeAlD
Amoxapine—HTR7—female reproductive system—urinary bladder cancer	0.00347	0.0141	CbGeAlD
Amoxapine—HRH1—smooth muscle tissue—urinary bladder cancer	0.00336	0.0136	CbGeAlD
Amoxapine—HRH1—urethra—urinary bladder cancer	0.00318	0.0129	CbGeAlD
Amoxapine—ADRA2A—urethra—urinary bladder cancer	0.00312	0.0126	CbGeAlD
Amoxapine—HTR2A—epithelium—urinary bladder cancer	0.00291	0.0118	CbGeAlD
Amoxapine—ORM1—lymph node—urinary bladder cancer	0.00281	0.0114	CbGeAlD
Amoxapine—HTR2A—smooth muscle tissue—urinary bladder cancer	0.00281	0.0114	CbGeAlD
Amoxapine—HTR2A—renal system—urinary bladder cancer	0.0027	0.0109	CbGeAlD
Amoxapine—HRH1—female reproductive system—urinary bladder cancer	0.00259	0.0105	CbGeAlD
Amoxapine—ADRA2A—female reproductive system—urinary bladder cancer	0.00255	0.0103	CbGeAlD
Amoxapine—CYP2D6—renal system—urinary bladder cancer	0.00246	0.00997	CbGeAlD
Amoxapine—HTR2B—lymph node—urinary bladder cancer	0.00237	0.0096	CbGeAlD
Amoxapine—HRH1—vagina—urinary bladder cancer	0.00234	0.00949	CbGeAlD
Amoxapine—ADRA2A—vagina—urinary bladder cancer	0.0023	0.00933	CbGeAlD
Amoxapine—HTR2A—female reproductive system—urinary bladder cancer	0.00217	0.00877	CbGeAlD
Amoxapine—SLC6A2—lymph node—urinary bladder cancer	0.00211	0.00853	CbGeAlD
Amoxapine—CYP2D6—female reproductive system—urinary bladder cancer	0.00197	0.00799	CbGeAlD
Amoxapine—HTR2A—vagina—urinary bladder cancer	0.00196	0.00793	CbGeAlD
Amoxapine—Oedema—Gemcitabine—urinary bladder cancer	0.00163	0.00228	CcSEcCtD
Amoxapine—Cerebrovascular accident—Epirubicin—urinary bladder cancer	0.00162	0.00227	CcSEcCtD
Amoxapine—Confusional state—Fluorouracil—urinary bladder cancer	0.00161	0.00227	CcSEcCtD
Amoxapine—Convulsion—Cisplatin—urinary bladder cancer	0.00161	0.00226	CcSEcCtD
Amoxapine—Oedema—Fluorouracil—urinary bladder cancer	0.0016	0.00225	CcSEcCtD
Amoxapine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00159	0.00224	CcSEcCtD
Amoxapine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00159	0.00224	CcSEcCtD
Amoxapine—Ataxia—Methotrexate—urinary bladder cancer	0.00159	0.00224	CcSEcCtD
Amoxapine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00158	0.00222	CcSEcCtD
Amoxapine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00156	0.0022	CcSEcCtD
Amoxapine—Tachycardia—Fluorouracil—urinary bladder cancer	0.00156	0.00219	CcSEcCtD
Amoxapine—Increased appetite—Doxorubicin—urinary bladder cancer	0.00156	0.00219	CcSEcCtD
Amoxapine—Anorexia—Gemcitabine—urinary bladder cancer	0.00155	0.00218	CcSEcCtD
Amoxapine—Urticaria—Thiotepa—urinary bladder cancer	0.00154	0.00216	CcSEcCtD
Amoxapine—Abdominal pain—Thiotepa—urinary bladder cancer	0.00153	0.00215	CcSEcCtD
Amoxapine—Body temperature increased—Thiotepa—urinary bladder cancer	0.00153	0.00215	CcSEcCtD
Amoxapine—Anorexia—Fluorouracil—urinary bladder cancer	0.00152	0.00214	CcSEcCtD
Amoxapine—Leukopenia—Etoposide—urinary bladder cancer	0.00152	0.00214	CcSEcCtD
Amoxapine—Purpura—Doxorubicin—urinary bladder cancer	0.00152	0.00214	CcSEcCtD
Amoxapine—Hypotension—Gemcitabine—urinary bladder cancer	0.00152	0.00213	CcSEcCtD
Amoxapine—HRH1—lymph node—urinary bladder cancer	0.00152	0.00614	CbGeAlD
Amoxapine—Oedema—Cisplatin—urinary bladder cancer	0.00152	0.00213	CcSEcCtD
Amoxapine—Loss of consciousness—Etoposide—urinary bladder cancer	0.00149	0.0021	CcSEcCtD
Amoxapine—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	0.00149	0.0021	CcSEcCtD
Amoxapine—Hypotension—Fluorouracil—urinary bladder cancer	0.00149	0.0021	CcSEcCtD
Amoxapine—ADRA2A—lymph node—urinary bladder cancer	0.00149	0.00603	CbGeAlD
Amoxapine—Ataxia—Epirubicin—urinary bladder cancer	0.00149	0.00209	CcSEcCtD
Amoxapine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00148	0.00209	CcSEcCtD
Amoxapine—Tachycardia—Cisplatin—urinary bladder cancer	0.00148	0.00208	CcSEcCtD
Amoxapine—Convulsion—Etoposide—urinary bladder cancer	0.00147	0.00207	CcSEcCtD
Amoxapine—Insomnia—Gemcitabine—urinary bladder cancer	0.00147	0.00207	CcSEcCtD
Amoxapine—Hypertension—Etoposide—urinary bladder cancer	0.00147	0.00206	CcSEcCtD
Amoxapine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00146	0.00205	CcSEcCtD
Amoxapine—Eosinophilia—Methotrexate—urinary bladder cancer	0.00145	0.00203	CcSEcCtD
Amoxapine—Insomnia—Fluorouracil—urinary bladder cancer	0.00145	0.00203	CcSEcCtD
Amoxapine—Somnolence—Gemcitabine—urinary bladder cancer	0.00145	0.00203	CcSEcCtD
Amoxapine—Anorexia—Cisplatin—urinary bladder cancer	0.00144	0.00203	CcSEcCtD
Amoxapine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00144	0.00202	CcSEcCtD
Amoxapine—Pancreatitis—Methotrexate—urinary bladder cancer	0.00143	0.00201	CcSEcCtD
Amoxapine—Somnolence—Fluorouracil—urinary bladder cancer	0.00142	0.002	CcSEcCtD
Amoxapine—Hypotension—Cisplatin—urinary bladder cancer	0.00142	0.00199	CcSEcCtD
Amoxapine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00141	0.00199	CcSEcCtD
Amoxapine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00141	0.00198	CcSEcCtD
Amoxapine—Fatigue—Gemcitabine—urinary bladder cancer	0.0014	0.00197	CcSEcCtD
Amoxapine—Confusional state—Etoposide—urinary bladder cancer	0.0014	0.00197	CcSEcCtD
Amoxapine—Constipation—Gemcitabine—urinary bladder cancer	0.00139	0.00195	CcSEcCtD
Amoxapine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00139	0.00195	CcSEcCtD
Amoxapine—Asthenia—Thiotepa—urinary bladder cancer	0.00139	0.00195	CcSEcCtD
Amoxapine—Ataxia—Doxorubicin—urinary bladder cancer	0.00138	0.00194	CcSEcCtD
Amoxapine—Pruritus—Thiotepa—urinary bladder cancer	0.00137	0.00192	CcSEcCtD
Amoxapine—Paraesthesia—Cisplatin—urinary bladder cancer	0.00136	0.00191	CcSEcCtD
Amoxapine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00136	0.00191	CcSEcCtD
Amoxapine—Tachycardia—Etoposide—urinary bladder cancer	0.00135	0.0019	CcSEcCtD
Amoxapine—Eosinophilia—Epirubicin—urinary bladder cancer	0.00135	0.0019	CcSEcCtD
Amoxapine—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.00135	0.00189	CcSEcCtD
Amoxapine—Pancreatitis—Epirubicin—urinary bladder cancer	0.00134	0.00189	CcSEcCtD
Amoxapine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00134	0.00188	CcSEcCtD
Amoxapine—Anorexia—Etoposide—urinary bladder cancer	0.00132	0.00186	CcSEcCtD
Amoxapine—Diarrhoea—Thiotepa—urinary bladder cancer	0.00132	0.00186	CcSEcCtD
Amoxapine—Decreased appetite—Cisplatin—urinary bladder cancer	0.00132	0.00185	CcSEcCtD
Amoxapine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00132	0.00185	CcSEcCtD
Amoxapine—Drowsiness—Methotrexate—urinary bladder cancer	0.0013	0.00183	CcSEcCtD
Amoxapine—Hypotension—Etoposide—urinary bladder cancer	0.0013	0.00182	CcSEcCtD
Amoxapine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00129	0.00181	CcSEcCtD
Amoxapine—Dizziness—Thiotepa—urinary bladder cancer	0.00128	0.0018	CcSEcCtD
Amoxapine—Stomatitis—Methotrexate—urinary bladder cancer	0.00127	0.00179	CcSEcCtD
Amoxapine—Urticaria—Fluorouracil—urinary bladder cancer	0.00127	0.00178	CcSEcCtD
Amoxapine—Pollakiuria—Epirubicin—urinary bladder cancer	0.00126	0.00178	CcSEcCtD
Amoxapine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00126	0.00178	CcSEcCtD
Amoxapine—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00125	0.00176	CcSEcCtD
Amoxapine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00125	0.00175	CcSEcCtD
Amoxapine—Paraesthesia—Etoposide—urinary bladder cancer	0.00125	0.00175	CcSEcCtD
Amoxapine—Weight increased—Epirubicin—urinary bladder cancer	0.00125	0.00175	CcSEcCtD
Amoxapine—Pancreatitis—Doxorubicin—urinary bladder cancer	0.00124	0.00174	CcSEcCtD
Amoxapine—Somnolence—Etoposide—urinary bladder cancer	0.00123	0.00173	CcSEcCtD
Amoxapine—Vomiting—Thiotepa—urinary bladder cancer	0.00123	0.00173	CcSEcCtD
Amoxapine—Drowsiness—Epirubicin—urinary bladder cancer	0.00122	0.00171	CcSEcCtD
Amoxapine—Rash—Thiotepa—urinary bladder cancer	0.00122	0.00171	CcSEcCtD
Amoxapine—Dermatitis—Thiotepa—urinary bladder cancer	0.00122	0.00171	CcSEcCtD
Amoxapine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00122	0.00171	CcSEcCtD
Amoxapine—Headache—Thiotepa—urinary bladder cancer	0.00121	0.0017	CcSEcCtD
Amoxapine—Decreased appetite—Etoposide—urinary bladder cancer	0.00121	0.0017	CcSEcCtD
Amoxapine—Body temperature increased—Cisplatin—urinary bladder cancer	0.0012	0.00168	CcSEcCtD
Amoxapine—Fatigue—Etoposide—urinary bladder cancer	0.0012	0.00168	CcSEcCtD
Amoxapine—Stomatitis—Epirubicin—urinary bladder cancer	0.00119	0.00167	CcSEcCtD
Amoxapine—Jaundice—Epirubicin—urinary bladder cancer	0.00119	0.00167	CcSEcCtD
Amoxapine—Constipation—Etoposide—urinary bladder cancer	0.00119	0.00167	CcSEcCtD
Amoxapine—Hepatitis—Methotrexate—urinary bladder cancer	0.00117	0.00164	CcSEcCtD
Amoxapine—Pollakiuria—Doxorubicin—urinary bladder cancer	0.00117	0.00164	CcSEcCtD
Amoxapine—Asthenia—Gemcitabine—urinary bladder cancer	0.00117	0.00164	CcSEcCtD
Amoxapine—Weight increased—Doxorubicin—urinary bladder cancer	0.00115	0.00162	CcSEcCtD
Amoxapine—Pruritus—Gemcitabine—urinary bladder cancer	0.00115	0.00162	CcSEcCtD
Amoxapine—Nausea—Thiotepa—urinary bladder cancer	0.00115	0.00161	CcSEcCtD
Amoxapine—Feeling abnormal—Etoposide—urinary bladder cancer	0.00114	0.00161	CcSEcCtD
Amoxapine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00114	0.0016	CcSEcCtD
Amoxapine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00114	0.0016	CcSEcCtD
Amoxapine—Pruritus—Fluorouracil—urinary bladder cancer	0.00113	0.00159	CcSEcCtD
Amoxapine—Drowsiness—Doxorubicin—urinary bladder cancer	0.00113	0.00159	CcSEcCtD
Amoxapine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00111	0.00156	CcSEcCtD
Amoxapine—Urticaria—Etoposide—urinary bladder cancer	0.0011	0.00155	CcSEcCtD
Amoxapine—Stomatitis—Doxorubicin—urinary bladder cancer	0.0011	0.00155	CcSEcCtD
Amoxapine—Jaundice—Doxorubicin—urinary bladder cancer	0.0011	0.00155	CcSEcCtD
Amoxapine—Abdominal pain—Etoposide—urinary bladder cancer	0.0011	0.00154	CcSEcCtD
Amoxapine—Body temperature increased—Etoposide—urinary bladder cancer	0.0011	0.00154	CcSEcCtD
Amoxapine—Hepatitis—Epirubicin—urinary bladder cancer	0.0011	0.00154	CcSEcCtD
Amoxapine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00109	0.00154	CcSEcCtD
Amoxapine—Tinnitus—Methotrexate—urinary bladder cancer	0.00109	0.00153	CcSEcCtD
Amoxapine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00109	0.00153	CcSEcCtD
Amoxapine—Asthenia—Cisplatin—urinary bladder cancer	0.00109	0.00153	CcSEcCtD
Amoxapine—Dizziness—Fluorouracil—urinary bladder cancer	0.00106	0.00149	CcSEcCtD
Amoxapine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00105	0.00148	CcSEcCtD
Amoxapine—Diarrhoea—Cisplatin—urinary bladder cancer	0.00104	0.00146	CcSEcCtD
Amoxapine—Alopecia—Methotrexate—urinary bladder cancer	0.00103	0.00145	CcSEcCtD
Amoxapine—Vomiting—Gemcitabine—urinary bladder cancer	0.00103	0.00145	CcSEcCtD
Amoxapine—Rash—Gemcitabine—urinary bladder cancer	0.00103	0.00144	CcSEcCtD
Amoxapine—Dermatitis—Gemcitabine—urinary bladder cancer	0.00102	0.00144	CcSEcCtD
Amoxapine—Tinnitus—Epirubicin—urinary bladder cancer	0.00102	0.00144	CcSEcCtD
Amoxapine—Headache—Gemcitabine—urinary bladder cancer	0.00102	0.00143	CcSEcCtD
Amoxapine—Vomiting—Fluorouracil—urinary bladder cancer	0.00102	0.00143	CcSEcCtD
Amoxapine—Hepatitis—Doxorubicin—urinary bladder cancer	0.00101	0.00142	CcSEcCtD
Amoxapine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00101	0.00142	CcSEcCtD
Amoxapine—Rash—Fluorouracil—urinary bladder cancer	0.00101	0.00142	CcSEcCtD
Amoxapine—Dermatitis—Fluorouracil—urinary bladder cancer	0.00101	0.00142	CcSEcCtD
Amoxapine—Headache—Fluorouracil—urinary bladder cancer	0.001	0.00141	CcSEcCtD
Amoxapine—Dysgeusia—Methotrexate—urinary bladder cancer	0.000998	0.0014	CcSEcCtD
Amoxapine—Asthenia—Etoposide—urinary bladder cancer	0.000996	0.0014	CcSEcCtD
Amoxapine—Pruritus—Etoposide—urinary bladder cancer	0.000982	0.00138	CcSEcCtD
Amoxapine—Alopecia—Epirubicin—urinary bladder cancer	0.000968	0.00136	CcSEcCtD
Amoxapine—Nausea—Gemcitabine—urinary bladder cancer	0.000966	0.00136	CcSEcCtD
Amoxapine—Vomiting—Cisplatin—urinary bladder cancer	0.000963	0.00135	CcSEcCtD
Amoxapine—Vision blurred—Methotrexate—urinary bladder cancer	0.00096	0.00135	CcSEcCtD
Amoxapine—Rash—Cisplatin—urinary bladder cancer	0.000955	0.00134	CcSEcCtD
Amoxapine—Dermatitis—Cisplatin—urinary bladder cancer	0.000955	0.00134	CcSEcCtD
Amoxapine—Diarrhoea—Etoposide—urinary bladder cancer	0.00095	0.00133	CcSEcCtD
Amoxapine—Nausea—Fluorouracil—urinary bladder cancer	0.000949	0.00133	CcSEcCtD
Amoxapine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000945	0.00133	CcSEcCtD
Amoxapine—Flatulence—Epirubicin—urinary bladder cancer	0.00094	0.00132	CcSEcCtD
Amoxapine—Tension—Epirubicin—urinary bladder cancer	0.000936	0.00131	CcSEcCtD
Amoxapine—Dysgeusia—Epirubicin—urinary bladder cancer	0.000934	0.00131	CcSEcCtD
Amoxapine—Nervousness—Epirubicin—urinary bladder cancer	0.000926	0.0013	CcSEcCtD
Amoxapine—Oxazepam—UGT2B7—urinary bladder cancer	0.00092	1	CrCbGaD
Amoxapine—Dizziness—Etoposide—urinary bladder cancer	0.000918	0.00129	CcSEcCtD
Amoxapine—Leukopenia—Methotrexate—urinary bladder cancer	0.000912	0.00128	CcSEcCtD
Amoxapine—Nausea—Cisplatin—urinary bladder cancer	0.0009	0.00126	CcSEcCtD
Amoxapine—Vision blurred—Epirubicin—urinary bladder cancer	0.000899	0.00126	CcSEcCtD
Amoxapine—Alopecia—Doxorubicin—urinary bladder cancer	0.000896	0.00126	CcSEcCtD
Amoxapine—Convulsion—Methotrexate—urinary bladder cancer	0.000883	0.00124	CcSEcCtD
Amoxapine—Vomiting—Etoposide—urinary bladder cancer	0.000883	0.00124	CcSEcCtD
Amoxapine—Agitation—Epirubicin—urinary bladder cancer	0.000876	0.00123	CcSEcCtD
Amoxapine—Rash—Etoposide—urinary bladder cancer	0.000875	0.00123	CcSEcCtD
Amoxapine—Dermatitis—Etoposide—urinary bladder cancer	0.000874	0.00123	CcSEcCtD
Amoxapine—Headache—Etoposide—urinary bladder cancer	0.00087	0.00122	CcSEcCtD
Amoxapine—Flatulence—Doxorubicin—urinary bladder cancer	0.000869	0.00122	CcSEcCtD
Amoxapine—Tension—Doxorubicin—urinary bladder cancer	0.000866	0.00122	CcSEcCtD
Amoxapine—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000864	0.00121	CcSEcCtD
Amoxapine—Nervousness—Doxorubicin—urinary bladder cancer	0.000857	0.0012	CcSEcCtD
Amoxapine—Syncope—Epirubicin—urinary bladder cancer	0.000855	0.0012	CcSEcCtD
Amoxapine—Leukopenia—Epirubicin—urinary bladder cancer	0.000853	0.0012	CcSEcCtD
Amoxapine—Palpitations—Epirubicin—urinary bladder cancer	0.000843	0.00118	CcSEcCtD
Amoxapine—Confusional state—Methotrexate—urinary bladder cancer	0.000838	0.00118	CcSEcCtD
Amoxapine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000838	0.00118	CcSEcCtD
Amoxapine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000831	0.00117	CcSEcCtD
Amoxapine—Convulsion—Epirubicin—urinary bladder cancer	0.000826	0.00116	CcSEcCtD
Amoxapine—Nausea—Etoposide—urinary bladder cancer	0.000825	0.00116	CcSEcCtD
Amoxapine—Hypertension—Epirubicin—urinary bladder cancer	0.000823	0.00116	CcSEcCtD
Amoxapine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000814	0.00114	CcSEcCtD
Amoxapine—Agitation—Doxorubicin—urinary bladder cancer	0.000811	0.00114	CcSEcCtD
Amoxapine—Dry mouth—Epirubicin—urinary bladder cancer	0.000794	0.00112	CcSEcCtD
Amoxapine—Anorexia—Methotrexate—urinary bladder cancer	0.000793	0.00111	CcSEcCtD
Amoxapine—Syncope—Doxorubicin—urinary bladder cancer	0.000791	0.00111	CcSEcCtD
Amoxapine—Leukopenia—Doxorubicin—urinary bladder cancer	0.00079	0.00111	CcSEcCtD
Amoxapine—Confusional state—Epirubicin—urinary bladder cancer	0.000785	0.0011	CcSEcCtD
Amoxapine—Palpitations—Doxorubicin—urinary bladder cancer	0.00078	0.0011	CcSEcCtD
Amoxapine—Oedema—Epirubicin—urinary bladder cancer	0.000778	0.00109	CcSEcCtD
Amoxapine—Hypotension—Methotrexate—urinary bladder cancer	0.000777	0.00109	CcSEcCtD
Amoxapine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000775	0.00109	CcSEcCtD
Amoxapine—Shock—Epirubicin—urinary bladder cancer	0.000766	0.00108	CcSEcCtD
Amoxapine—Convulsion—Doxorubicin—urinary bladder cancer	0.000764	0.00107	CcSEcCtD
Amoxapine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000762	0.00107	CcSEcCtD
Amoxapine—Hypertension—Doxorubicin—urinary bladder cancer	0.000762	0.00107	CcSEcCtD
Amoxapine—Tachycardia—Epirubicin—urinary bladder cancer	0.000759	0.00107	CcSEcCtD
Amoxapine—Insomnia—Methotrexate—urinary bladder cancer	0.000752	0.00106	CcSEcCtD
Amoxapine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000747	0.00105	CcSEcCtD
Amoxapine—Anorexia—Epirubicin—urinary bladder cancer	0.000742	0.00104	CcSEcCtD
Amoxapine—Somnolence—Methotrexate—urinary bladder cancer	0.000739	0.00104	CcSEcCtD
Amoxapine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000735	0.00103	CcSEcCtD
Amoxapine—Dyspepsia—Methotrexate—urinary bladder cancer	0.000732	0.00103	CcSEcCtD
Amoxapine—Hypotension—Epirubicin—urinary bladder cancer	0.000727	0.00102	CcSEcCtD
Amoxapine—Confusional state—Doxorubicin—urinary bladder cancer	0.000726	0.00102	CcSEcCtD
Amoxapine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000723	0.00102	CcSEcCtD
Amoxapine—Oedema—Doxorubicin—urinary bladder cancer	0.00072	0.00101	CcSEcCtD
Amoxapine—Fatigue—Methotrexate—urinary bladder cancer	0.000717	0.00101	CcSEcCtD
Amoxapine—Shock—Doxorubicin—urinary bladder cancer	0.000708	0.000996	CcSEcCtD
Amoxapine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000705	0.000991	CcSEcCtD
Amoxapine—Insomnia—Epirubicin—urinary bladder cancer	0.000704	0.000989	CcSEcCtD
Amoxapine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000703	0.000988	CcSEcCtD
Amoxapine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000699	0.000982	CcSEcCtD
Amoxapine—Somnolence—Epirubicin—urinary bladder cancer	0.000692	0.000972	CcSEcCtD
Amoxapine—Anorexia—Doxorubicin—urinary bladder cancer	0.000686	0.000965	CcSEcCtD
Amoxapine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000685	0.000963	CcSEcCtD
Amoxapine—Dyspepsia—Epirubicin—urinary bladder cancer	0.000685	0.000963	CcSEcCtD
Amoxapine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00068	0.000956	CcSEcCtD
Amoxapine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000676	0.000951	CcSEcCtD
Amoxapine—Hypotension—Doxorubicin—urinary bladder cancer	0.000673	0.000946	CcSEcCtD
Amoxapine—Fatigue—Epirubicin—urinary bladder cancer	0.000671	0.000943	CcSEcCtD
Amoxapine—Constipation—Epirubicin—urinary bladder cancer	0.000665	0.000935	CcSEcCtD
Amoxapine—Urticaria—Methotrexate—urinary bladder cancer	0.000661	0.000928	CcSEcCtD
Amoxapine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000657	0.000924	CcSEcCtD
Amoxapine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000657	0.000924	CcSEcCtD
Amoxapine—Insomnia—Doxorubicin—urinary bladder cancer	0.000651	0.000915	CcSEcCtD
Amoxapine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000647	0.000909	CcSEcCtD
Amoxapine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000641	0.000901	CcSEcCtD
Amoxapine—Somnolence—Doxorubicin—urinary bladder cancer	0.00064	0.0009	CcSEcCtD
Amoxapine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000636	0.000894	CcSEcCtD
Amoxapine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000634	0.000891	CcSEcCtD
Amoxapine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000626	0.00088	CcSEcCtD
Amoxapine—Fatigue—Doxorubicin—urinary bladder cancer	0.000621	0.000872	CcSEcCtD
Amoxapine—Urticaria—Epirubicin—urinary bladder cancer	0.000618	0.000869	CcSEcCtD
Amoxapine—Constipation—Doxorubicin—urinary bladder cancer	0.000616	0.000865	CcSEcCtD
Amoxapine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000615	0.000865	CcSEcCtD
Amoxapine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000615	0.000865	CcSEcCtD
Amoxapine—Asthenia—Methotrexate—urinary bladder cancer	0.000597	0.000838	CcSEcCtD
Amoxapine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000593	0.000834	CcSEcCtD
Amoxapine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000589	0.000827	CcSEcCtD
Amoxapine—Pruritus—Methotrexate—urinary bladder cancer	0.000588	0.000827	CcSEcCtD
Amoxapine—Urticaria—Doxorubicin—urinary bladder cancer	0.000572	0.000804	CcSEcCtD
Amoxapine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000569	0.0008	CcSEcCtD
Amoxapine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000569	0.0008	CcSEcCtD
Amoxapine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000569	0.0008	CcSEcCtD
Amoxapine—Asthenia—Epirubicin—urinary bladder cancer	0.000558	0.000785	CcSEcCtD
Amoxapine—Pruritus—Epirubicin—urinary bladder cancer	0.000551	0.000774	CcSEcCtD
Amoxapine—Dizziness—Methotrexate—urinary bladder cancer	0.00055	0.000773	CcSEcCtD
Amoxapine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000532	0.000748	CcSEcCtD
Amoxapine—Vomiting—Methotrexate—urinary bladder cancer	0.000529	0.000743	CcSEcCtD
Amoxapine—Rash—Methotrexate—urinary bladder cancer	0.000524	0.000737	CcSEcCtD
Amoxapine—Dermatitis—Methotrexate—urinary bladder cancer	0.000524	0.000736	CcSEcCtD
Amoxapine—Headache—Methotrexate—urinary bladder cancer	0.000521	0.000732	CcSEcCtD
Amoxapine—Asthenia—Doxorubicin—urinary bladder cancer	0.000517	0.000726	CcSEcCtD
Amoxapine—Dizziness—Epirubicin—urinary bladder cancer	0.000515	0.000723	CcSEcCtD
Amoxapine—Pruritus—Doxorubicin—urinary bladder cancer	0.000509	0.000716	CcSEcCtD
Amoxapine—Vomiting—Epirubicin—urinary bladder cancer	0.000495	0.000695	CcSEcCtD
Amoxapine—Nausea—Methotrexate—urinary bladder cancer	0.000494	0.000694	CcSEcCtD
Amoxapine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000493	0.000692	CcSEcCtD
Amoxapine—Rash—Epirubicin—urinary bladder cancer	0.000491	0.00069	CcSEcCtD
Amoxapine—Dermatitis—Epirubicin—urinary bladder cancer	0.00049	0.000689	CcSEcCtD
Amoxapine—Headache—Epirubicin—urinary bladder cancer	0.000487	0.000685	CcSEcCtD
Amoxapine—Dizziness—Doxorubicin—urinary bladder cancer	0.000476	0.000669	CcSEcCtD
Amoxapine—Nausea—Epirubicin—urinary bladder cancer	0.000462	0.00065	CcSEcCtD
Amoxapine—Vomiting—Doxorubicin—urinary bladder cancer	0.000458	0.000643	CcSEcCtD
Amoxapine—Rash—Doxorubicin—urinary bladder cancer	0.000454	0.000638	CcSEcCtD
Amoxapine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000454	0.000637	CcSEcCtD
Amoxapine—Headache—Doxorubicin—urinary bladder cancer	0.000451	0.000634	CcSEcCtD
Amoxapine—Nausea—Doxorubicin—urinary bladder cancer	0.000428	0.000601	CcSEcCtD
Amoxapine—ADRA1A—Signaling Pathways—ESR1—urinary bladder cancer	8.54e-06	0.00021	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—PTEN—urinary bladder cancer	8.53e-06	0.00021	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—PTEN—urinary bladder cancer	8.52e-06	0.00021	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—ERBB2—urinary bladder cancer	8.5e-06	0.000209	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CCND1—urinary bladder cancer	8.45e-06	0.000208	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—MMP9—urinary bladder cancer	8.34e-06	0.000205	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—CREBBP—urinary bladder cancer	8.31e-06	0.000205	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CDKN1A—urinary bladder cancer	8.31e-06	0.000205	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—PTEN—urinary bladder cancer	8.29e-06	0.000204	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—IL2—urinary bladder cancer	8.28e-06	0.000204	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—KRAS—urinary bladder cancer	8.21e-06	0.000202	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MMP9—urinary bladder cancer	8.21e-06	0.000202	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CDKN1A—urinary bladder cancer	8.18e-06	0.000201	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CXCL8—urinary bladder cancer	8.17e-06	0.000201	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—KRAS—urinary bladder cancer	8.17e-06	0.000201	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—FGFR3—urinary bladder cancer	8.17e-06	0.000201	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—PTEN—urinary bladder cancer	8.16e-06	0.000201	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—EP300—urinary bladder cancer	8.14e-06	0.0002	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—EP300—urinary bladder cancer	8.13e-06	0.0002	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—HRAS—urinary bladder cancer	8.12e-06	0.0002	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CCND1—urinary bladder cancer	8.07e-06	0.000199	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CXCL8—urinary bladder cancer	8.06e-06	0.000199	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—HRAS—urinary bladder cancer	8.01e-06	0.000197	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—RHOA—urinary bladder cancer	8e-06	0.000197	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	7.96e-06	0.000196	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—RHOA—urinary bladder cancer	7.96e-06	0.000196	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ESR1—urinary bladder cancer	7.93e-06	0.000195	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—SRC—urinary bladder cancer	7.91e-06	0.000195	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—EP300—urinary bladder cancer	7.91e-06	0.000195	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—SRC—urinary bladder cancer	7.91e-06	0.000195	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	7.87e-06	0.000194	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	7.87e-06	0.000194	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MMP9—urinary bladder cancer	7.84e-06	0.000193	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—IL2—urinary bladder cancer	7.81e-06	0.000192	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CDKN1A—urinary bladder cancer	7.81e-06	0.000192	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—PTEN—urinary bladder cancer	7.79e-06	0.000192	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—EP300—urinary bladder cancer	7.78e-06	0.000192	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CREBBP—urinary bladder cancer	7.77e-06	0.000191	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—IL2—urinary bladder cancer	7.7e-06	0.00019	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—SRC—urinary bladder cancer	7.69e-06	0.000189	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IGF1—urinary bladder cancer	7.67e-06	0.000189	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CREBBP—urinary bladder cancer	7.64e-06	0.000188	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—EGFR—urinary bladder cancer	7.63e-06	0.000188	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CREBBP—urinary bladder cancer	7.63e-06	0.000188	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CCND1—urinary bladder cancer	7.61e-06	0.000187	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CREBBP—urinary bladder cancer	7.6e-06	0.000187	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—SRC—urinary bladder cancer	7.57e-06	0.000186	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IGF1—urinary bladder cancer	7.55e-06	0.000186	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	7.54e-06	0.000186	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IGF1—urinary bladder cancer	7.53e-06	0.000185	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CCND1—urinary bladder cancer	7.51e-06	0.000185	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—EGFR—urinary bladder cancer	7.51e-06	0.000185	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IGF1—urinary bladder cancer	7.51e-06	0.000185	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—EGFR—urinary bladder cancer	7.49e-06	0.000185	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CREBBP—urinary bladder cancer	7.48e-06	0.000184	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—EGFR—urinary bladder cancer	7.47e-06	0.000184	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—EP300—urinary bladder cancer	7.43e-06	0.000183	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—ERBB2—urinary bladder cancer	7.41e-06	0.000182	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	7.4e-06	0.000182	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IGF1—urinary bladder cancer	7.39e-06	0.000182	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MMP9—urinary bladder cancer	7.39e-06	0.000182	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—ERBB2—urinary bladder cancer	7.37e-06	0.000181	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CDKN1A—urinary bladder cancer	7.36e-06	0.000181	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—EGFR—urinary bladder cancer	7.35e-06	0.000181	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—PTEN—urinary bladder cancer	7.35e-06	0.000181	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MMP9—urinary bladder cancer	7.29e-06	0.00018	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CDKN1A—urinary bladder cancer	7.27e-06	0.000179	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—PTEN—urinary bladder cancer	7.25e-06	0.000179	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—SRC—urinary bladder cancer	7.22e-06	0.000178	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—KRAS—urinary bladder cancer	7.21e-06	0.000178	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—KRAS—urinary bladder cancer	7.09e-06	0.000175	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—MYC—urinary bladder cancer	7.09e-06	0.000175	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—MYC—urinary bladder cancer	7.08e-06	0.000174	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—KRAS—urinary bladder cancer	7.08e-06	0.000174	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—KRAS—urinary bladder cancer	7.06e-06	0.000174	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—RHOA—urinary bladder cancer	7.03e-06	0.000173	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CXCL8—urinary bladder cancer	7.03e-06	0.000173	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—EP300—urinary bladder cancer	7.01e-06	0.000173	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CXCL8—urinary bladder cancer	6.99e-06	0.000172	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—HRAS—urinary bladder cancer	6.98e-06	0.000172	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	6.96e-06	0.000171	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CREBBP—urinary bladder cancer	6.95e-06	0.000171	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—KRAS—urinary bladder cancer	6.95e-06	0.000171	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—HRAS—urinary bladder cancer	6.94e-06	0.000171	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—EGFR—urinary bladder cancer	6.94e-06	0.000171	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—EGFR—urinary bladder cancer	6.93e-06	0.000171	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—RHOA—urinary bladder cancer	6.91e-06	0.00017	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—EP300—urinary bladder cancer	6.91e-06	0.00017	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—RHOA—urinary bladder cancer	6.9e-06	0.00017	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—MYC—urinary bladder cancer	6.89e-06	0.00017	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—RHOA—urinary bladder cancer	6.88e-06	0.000169	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IGF1—urinary bladder cancer	6.87e-06	0.000169	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—EGFR—urinary bladder cancer	6.83e-06	0.000168	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—SRC—urinary bladder cancer	6.81e-06	0.000168	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PTGS2—urinary bladder cancer	6.81e-06	0.000168	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—MYC—urinary bladder cancer	6.78e-06	0.000167	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—RHOA—urinary bladder cancer	6.77e-06	0.000167	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—EGFR—urinary bladder cancer	6.74e-06	0.000166	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—SRC—urinary bladder cancer	6.72e-06	0.000166	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—IL2—urinary bladder cancer	6.71e-06	0.000165	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—IL2—urinary bladder cancer	6.68e-06	0.000164	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—EGFR—urinary bladder cancer	6.63e-06	0.000163	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—KRAS—urinary bladder cancer	6.55e-06	0.000161	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—KRAS—urinary bladder cancer	6.55e-06	0.000161	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CCND1—urinary bladder cancer	6.55e-06	0.000161	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CCND1—urinary bladder cancer	6.51e-06	0.00016	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—ERBB2—urinary bladder cancer	6.5e-06	0.00016	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—MYC—urinary bladder cancer	6.47e-06	0.000159	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—KRAS—urinary bladder cancer	6.45e-06	0.000159	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—ERBB2—urinary bladder cancer	6.4e-06	0.000158	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—ERBB2—urinary bladder cancer	6.39e-06	0.000157	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—KRAS—urinary bladder cancer	6.37e-06	0.000157	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—ERBB2—urinary bladder cancer	6.37e-06	0.000157	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MMP9—urinary bladder cancer	6.35e-06	0.000156	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—EGFR—urinary bladder cancer	6.33e-06	0.000156	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CDKN1A—urinary bladder cancer	6.33e-06	0.000156	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MMP9—urinary bladder cancer	6.32e-06	0.000156	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—PTEN—urinary bladder cancer	6.32e-06	0.000156	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CDKN1A—urinary bladder cancer	6.3e-06	0.000155	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—RHOA—urinary bladder cancer	6.29e-06	0.000155	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—PTEN—urinary bladder cancer	6.28e-06	0.000155	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—ERBB2—urinary bladder cancer	6.27e-06	0.000154	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—KRAS—urinary bladder cancer	6.27e-06	0.000154	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CXCL8—urinary bladder cancer	6.17e-06	0.000152	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—HRAS—urinary bladder cancer	6.13e-06	0.000151	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—MYC—urinary bladder cancer	6.11e-06	0.00015	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CXCL8—urinary bladder cancer	6.07e-06	0.000149	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CXCL8—urinary bladder cancer	6.06e-06	0.000149	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CXCL8—urinary bladder cancer	6.04e-06	0.000149	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—HRAS—urinary bladder cancer	6.03e-06	0.000148	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—EP300—urinary bladder cancer	6.02e-06	0.000148	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—MYC—urinary bladder cancer	6.02e-06	0.000148	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—HRAS—urinary bladder cancer	6.02e-06	0.000148	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—HRAS—urinary bladder cancer	6e-06	0.000148	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—EP300—urinary bladder cancer	5.99e-06	0.000148	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—KRAS—urinary bladder cancer	5.98e-06	0.000147	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—EGFR—urinary bladder cancer	5.97e-06	0.000147	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CXCL8—urinary bladder cancer	5.94e-06	0.000146	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—PTEN—urinary bladder cancer	5.94e-06	0.000146	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—HRAS—urinary bladder cancer	5.9e-06	0.000145	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—IL2—urinary bladder cancer	5.89e-06	0.000145	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—EGFR—urinary bladder cancer	5.89e-06	0.000145	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—SRC—urinary bladder cancer	5.86e-06	0.000144	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—SRC—urinary bladder cancer	5.83e-06	0.000144	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TP53—urinary bladder cancer	5.82e-06	0.000143	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ERBB2—urinary bladder cancer	5.82e-06	0.000143	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TP53—urinary bladder cancer	5.82e-06	0.000143	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—IL2—urinary bladder cancer	5.8e-06	0.000143	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—IL2—urinary bladder cancer	5.79e-06	0.000143	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—IL2—urinary bladder cancer	5.77e-06	0.000142	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCND1—urinary bladder cancer	5.75e-06	0.000142	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—IL2—urinary bladder cancer	5.68e-06	0.00014	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—EP300—urinary bladder cancer	5.66e-06	0.000139	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TP53—urinary bladder cancer	5.66e-06	0.000139	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCND1—urinary bladder cancer	5.65e-06	0.000139	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCND1—urinary bladder cancer	5.64e-06	0.000139	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—KRAS—urinary bladder cancer	5.64e-06	0.000139	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	5.64e-06	0.000139	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCND1—urinary bladder cancer	5.62e-06	0.000138	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MMP9—urinary bladder cancer	5.58e-06	0.000137	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—HRAS—urinary bladder cancer	5.57e-06	0.000137	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TP53—urinary bladder cancer	5.57e-06	0.000137	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—KRAS—urinary bladder cancer	5.57e-06	0.000137	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—HRAS—urinary bladder cancer	5.56e-06	0.000137	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CDKN1A—urinary bladder cancer	5.56e-06	0.000137	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—PTEN—urinary bladder cancer	5.55e-06	0.000137	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCND1—urinary bladder cancer	5.54e-06	0.000136	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CXCL8—urinary bladder cancer	5.52e-06	0.000136	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MMP9—urinary bladder cancer	5.49e-06	0.000135	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—HRAS—urinary bladder cancer	5.49e-06	0.000135	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MMP9—urinary bladder cancer	5.48e-06	0.000135	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CDKN1A—urinary bladder cancer	5.47e-06	0.000135	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MMP9—urinary bladder cancer	5.46e-06	0.000134	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CDKN1A—urinary bladder cancer	5.46e-06	0.000134	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—PTEN—urinary bladder cancer	5.46e-06	0.000134	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—PTEN—urinary bladder cancer	5.45e-06	0.000134	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CDKN1A—urinary bladder cancer	5.44e-06	0.000134	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—PTEN—urinary bladder cancer	5.43e-06	0.000134	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	5.42e-06	0.000133	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—HRAS—urinary bladder cancer	5.41e-06	0.000133	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MMP9—urinary bladder cancer	5.38e-06	0.000132	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CDKN1A—urinary bladder cancer	5.36e-06	0.000132	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—PTEN—urinary bladder cancer	5.34e-06	0.000132	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—HRAS—urinary bladder cancer	5.33e-06	0.000131	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TP53—urinary bladder cancer	5.32e-06	0.000131	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—EP300—urinary bladder cancer	5.29e-06	0.00013	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—IL2—urinary bladder cancer	5.28e-06	0.00013	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—MYC—urinary bladder cancer	5.25e-06	0.000129	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—MYC—urinary bladder cancer	5.22e-06	0.000129	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—EP300—urinary bladder cancer	5.2e-06	0.000128	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—EP300—urinary bladder cancer	5.19e-06	0.000128	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—EP300—urinary bladder cancer	5.18e-06	0.000127	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCND1—urinary bladder cancer	5.14e-06	0.000127	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—SRC—urinary bladder cancer	5.14e-06	0.000127	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—EGFR—urinary bladder cancer	5.14e-06	0.000126	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—EGFR—urinary bladder cancer	5.11e-06	0.000126	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—EP300—urinary bladder cancer	5.1e-06	0.000126	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—HRAS—urinary bladder cancer	5.08e-06	0.000125	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—SRC—urinary bladder cancer	5.06e-06	0.000125	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—SRC—urinary bladder cancer	5.05e-06	0.000124	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—SRC—urinary bladder cancer	5.03e-06	0.000124	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TP53—urinary bladder cancer	5.01e-06	0.000123	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MMP9—urinary bladder cancer	4.99e-06	0.000123	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CDKN1A—urinary bladder cancer	4.98e-06	0.000123	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—PTEN—urinary bladder cancer	4.97e-06	0.000122	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—SRC—urinary bladder cancer	4.96e-06	0.000122	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TP53—urinary bladder cancer	4.95e-06	0.000122	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—KRAS—urinary bladder cancer	4.85e-06	0.000119	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—KRAS—urinary bladder cancer	4.83e-06	0.000119	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—HRAS—urinary bladder cancer	4.8e-06	0.000118	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—EP300—urinary bladder cancer	4.74e-06	0.000117	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—HRAS—urinary bladder cancer	4.73e-06	0.000117	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—MYC—urinary bladder cancer	4.61e-06	0.000114	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—SRC—urinary bladder cancer	4.6e-06	0.000113	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—MYC—urinary bladder cancer	4.54e-06	0.000112	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—MYC—urinary bladder cancer	4.53e-06	0.000111	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—MYC—urinary bladder cancer	4.51e-06	0.000111	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—EGFR—urinary bladder cancer	4.51e-06	0.000111	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—MYC—urinary bladder cancer	4.44e-06	0.000109	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	4.44e-06	0.000109	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—EGFR—urinary bladder cancer	4.44e-06	0.000109	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—EGFR—urinary bladder cancer	4.43e-06	0.000109	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—EGFR—urinary bladder cancer	4.41e-06	0.000109	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—EGFR—urinary bladder cancer	4.34e-06	0.000107	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TP53—urinary bladder cancer	4.31e-06	0.000106	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TP53—urinary bladder cancer	4.29e-06	0.000106	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—KRAS—urinary bladder cancer	4.26e-06	0.000105	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—KRAS—urinary bladder cancer	4.19e-06	0.000103	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—KRAS—urinary bladder cancer	4.18e-06	0.000103	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—KRAS—urinary bladder cancer	4.17e-06	0.000103	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—MYC—urinary bladder cancer	4.13e-06	0.000102	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—HRAS—urinary bladder cancer	4.12e-06	0.000102	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—KRAS—urinary bladder cancer	4.1e-06	0.000101	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—HRAS—urinary bladder cancer	4.1e-06	0.000101	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—EGFR—urinary bladder cancer	4.04e-06	9.94e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	3.87e-06	9.53e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—KRAS—urinary bladder cancer	3.81e-06	9.39e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TP53—urinary bladder cancer	3.79e-06	9.32e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TP53—urinary bladder cancer	3.72e-06	9.17e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TP53—urinary bladder cancer	3.72e-06	9.15e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TP53—urinary bladder cancer	3.7e-06	9.12e-05	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—EP300—urinary bladder cancer	3.69e-06	9.09e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TP53—urinary bladder cancer	3.65e-06	8.98e-05	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—HRAS—urinary bladder cancer	3.62e-06	8.92e-05	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—HRAS—urinary bladder cancer	3.56e-06	8.77e-05	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—HRAS—urinary bladder cancer	3.55e-06	8.75e-05	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—HRAS—urinary bladder cancer	3.54e-06	8.73e-05	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—HRAS—urinary bladder cancer	3.49e-06	8.59e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TP53—urinary bladder cancer	3.39e-06	8.34e-05	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—HRAS—urinary bladder cancer	3.24e-06	7.98e-05	CbGpPWpGaD
